Comment on: Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial
- PMID: 34653353
- DOI: 10.1016/j.ajo.2021.05.033
Comment on: Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial
Comment in
-
Reply to Comment on: "Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial".Am J Ophthalmol. 2022 Feb;234:329. doi: 10.1016/j.ajo.2021.09.039. Epub 2021 Oct 12. Am J Ophthalmol. 2022. PMID: 34653356 No abstract available.
Comment on
-
Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI From the iStent inject® Pivotal Trial.Am J Ophthalmol. 2021 Sep;229:220-229. doi: 10.1016/j.ajo.2021.03.007. Epub 2021 Mar 15. Am J Ophthalmol. 2021. PMID: 33737036 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
